131 related articles for article (PubMed ID: 38711180)
1. Intralesional curettage and surgical adjuvants in the treatment of giant cell tumor of bone: meta-analysis and systematic review.
Leng A; Gao H; Li J; Meng L; Wang Q; Xiang L
Chin Clin Oncol; 2024 Apr; 13(2):20. PubMed ID: 38711180
[TBL] [Abstract][Full Text] [Related]
2. Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis.
Zuo D; Zheng L; Sun W; Fu D; Hua Y; Cai Z
World J Surg Oncol; 2013 Jul; 11():156. PubMed ID: 23866921
[TBL] [Abstract][Full Text] [Related]
3. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
van der Heijden L; van de Sande MA; Dijkstra PD
Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
[TBL] [Abstract][Full Text] [Related]
5. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
7. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
8. [Intralesional curettage and wide excision for treatment of giant cell tumors (GCTs) of the distal radius: A Meta-analysis].
Yin ZC; Liu BG; Pang QJ; Chen XJ; Yu X
Zhongguo Gu Shang; 2016 Jan; 29(1):58-64. PubMed ID: 27019899
[TBL] [Abstract][Full Text] [Related]
9. Extended Curettage for Giant Cell Tumors of Bone: A Surgeon's View.
Gundavda MK; Agarwal MG
JBJS Essent Surg Tech; 2021; 11(3):. PubMed ID: 34650828
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for recurrent giant cell tumors of bone.
Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
[TBL] [Abstract][Full Text] [Related]
11. Management of giant cell tumors of the distal radius: a systematic review and meta-analysis.
Koucheki R; Gazendam A; Perera J; Griffin A; Ferguson P; Wunder J; Tsoi K
Eur J Orthop Surg Traumatol; 2023 May; 33(4):759-772. PubMed ID: 35377078
[TBL] [Abstract][Full Text] [Related]
12. Which treatment is the best for giant cell tumors of the distal radius? A meta-analysis.
Liu YP; Li KH; Sun BH
Clin Orthop Relat Res; 2012 Oct; 470(10):2886-94. PubMed ID: 22773395
[TBL] [Abstract][Full Text] [Related]
13. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
14. Does the use of polymethyl-methacrylate cement after intralesional curettage of giant cell tumors of appendicular bone guarantee reduced local recurrence rates? A retrospective analysis.
Colding-Rasmussen T; Horstmann PF; Jørgensen PH; Hettwer W; Hansen BH; Tierp-Wong CNE; Petersen MM
J Orthop Surg (Hong Kong); 2023; 31(3):10225536231202155. PubMed ID: 37688488
[TBL] [Abstract][Full Text] [Related]
15. The impact of curettage technique on local control in giant cell tumour of bone.
Machak GN; Snetkov AI
Int Orthop; 2021 Mar; 45(3):779-789. PubMed ID: 33094400
[TBL] [Abstract][Full Text] [Related]
16. Present day controversies and consensus in curettage for giant cell tumor of bone.
Errani C; Tsukamoto S; Ciani G; Donati DM
J Clin Orthop Trauma; 2019; 10(6):1015-1020. PubMed ID: 31736607
[TBL] [Abstract][Full Text] [Related]
17. In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage.
Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Zhang WB; Lu Y
Radiol Med; 2014 Nov; 119(11):861-70. PubMed ID: 24604549
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
[TBL] [Abstract][Full Text] [Related]
19. Current status of bone cementing and bone grafting for giant cell tumour of bone: a systemic review.
Vaishya R; Pokhrel A; Agarwal AK; Vijay V
Ann R Coll Surg Engl; 2019 Feb; 101(2):79-85. PubMed ID: 30688529
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
Tsukamoto S; Mavrogenis AF; Akahane M; Honoki K; Kido A; Tanaka Y; Donati DM; Errani C
BMC Musculoskelet Disord; 2022 May; 23(1):477. PubMed ID: 35590280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
